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Abstract
Background: Pinopods concentrations in endometrial surface is a marker of
implantation. Estradiol valerate (EV) was used to change the adverse effects of
Clomiphene Citrate (CC) on the endometrium.
Objective: The goal was to assess whether there is a significant difference in the
endometrial pinopods concentrations and other parameters after adding EV and
progesterone to higher doses of CC.
Materials and Methods: In this prospective randomized clinical trial, a total of 30
women who did not respond to 100 mg of CC from February 2016 to June 2016 were
evaluated. They were divided into three groups: group I) received 150 mg of CC alone,
group II) CC with EV, and group III) CC plus progesterone. On day 21 of the menstrual
cycle, endometrial biopsy, a blood sampling, and a scanning by electron microscopy
were performed.
Results: On day 21 of the menstrual cycle, there was no significant difference in the
pinopods concentrations (p = 0.641) and serum estrogen levels (p = 0.276) between
groups. However, the Serum progesterone levels in group I was higher than the other
two groups (p = 0.007) in the same day.
Conclusion: Since the addition of EV and progesterone to higher dosages of CC did
not change the pinopods concentration and serum estrogen levels on day 21 of the
menstrual cycle, and the serum progesterone levels was higher in CC alone group (i.e.
group I) compared to other groups, it can be concluded that the anti-estrogenic effects
of CC just appear on the endometrium and not on the plasma levels.
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1. Introduction
Induction of ovulation is one of the first steps
of infertility treatment among infertile couples
who have polycystic ovarian syndrome, or other
causes of infertility such as unexplained infertility.
Clomiphene citrate (CC) is a known and proven
first-line treatment for ovulation induction (1). Data
confirms that ovulation rate with this method is
about 80%, but pregnancy rates are about 40%
(2).
Different factors such as unexplained infertility
might cause the lower rate of pregnancy
after successful induction, but it should be
noted that anti-estrogenic effects of CC on
the endometrium can lead to disturbances in
endometrium during implantation. This effect
is dose-dependent and further increases in
dosage makes this problem more visible
(3). Estrogen can cause endometrial cell
proliferation and also increase the cells surface
microvillus, change the cell volume, and increase
progesterone receptors; this can all support the
hypothesis regarding the effect of exogenous
administered estrogen during ovulatory cycle on
pregnancy rate (4). Progesterone can cause
the uterine glands to become wider and
more complex and it also might increase their
activity (5). To reduce this effect, researchers
have used other drugs such as tamoxifen
as ovulation-stimulating agent believing it
might have less anti-estrogen effect on the
endometrium and less impact on the cervical score
(6).
In some studies, addition of conjugated
estrogens in the second half of the follicular
phase to compensate for the anti-estrogenic
effect of clomiphene has been evaluated
(7), but no study was done at the cellular
levels and endometrial morphology. Pinopods
are bubbles-like projections found on the
apical surface of the endometrial epithelium.
These organelles are some micrometers
wide and protrude into the uterine cavity
over the microvilli level. Electron microscopy
is the main instrument used to illustrate
these organelles. Pinopod expression is
restricted to a short-term period of maximal
two days in the menstrual cycle presumably
in the implantation window. The pinopod
expression pattern all over the menstrual cycle
supports their use as markers of implantation.
HOXA-10 is part of a homeobox gene that
its expression is essential for endometrial
receptiveness to blastocyst attachment. However,
it has a crucial role in pinopod growth (8).
Undeniably, suppressing HOXA-10 leads to
reduction in the number of pinopods. In some
study, CC leads to a decrease in HOXA-
10 and may cause lower pregnancy rate
(9).
Therefore, in this research, we tried to examine
pinopod concentration in the CC-treated group
alone compared with adding estradiol or
progesterone to see whether these changes
in pinopod concentrations could be reversed by
hormonal intervention. Our hypothesis was that
adding estradiol valerate (EV) and progesterone
to higher doses of CC could improve endometrial
morphology such as pinopods concentration
assessed by electron microscopy and other
factors affecting implantation, so that the addition
may improve implantation compared to CC
alone.
2. Materials and Methods
2.1. Patients
Thirty infertile patients were randomly divided
into three groups from February to June 2016 (n
= 10/each). The inclusion criteria were woman
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aged ≤ 35 yr and regular menses (25-34
days), and unexplained infertility for at least
1 yr. All patients had normal serum levels of
thyroid-stimulating hormone, and prolactin. Also,
all participants had a history of unsuccessful
usage of CC 100 mg/day in prior cycles.
The exclusion criteria were previous in-vitro
fertilization or intra-cytoplasmic sperm injection,
any other causes of infertility such as hyper
prolactinemia, thyroid causes, endometriosis,
ovulatory dysfunction, and uterine factors. The
flowchart of eligible patients has been shown in
Figure 1.
2.2. Ultrastructure of pinopods
In the present study, three methods of
ovulation induction in infertile patients were
used. For the effect of drugs on pinopods
concentration and embryo implantation the
endometrium was evaluated at the mid-luteal
phase (time of implantation). The first group
received 150 mg of CC (Aboraihan Company,
Tehran, Iran) alone on days 5-9 of menstrual
cycle. The second group in addition to 150
mg of CC on days 5-9 of menstrual cycle
received EV (Aboraihan Company, Tehran,
Iran) for five days from day 8 of menstrual
cycle at a dose of 4 mg daily. In the third
group, in addition to clomiphene on days 5-
9 of menstrual cycle, medroxyprogesterone
acetate (Aboraihan company, Tehran, Iran) 10
mg daily was prescribed from day 14 until the
time of biopsy on day 21 of the menstrual cycle
(II).
After the documentation of dominant follicles
by the ultrasound in ovaries, 10,000 IU/l HCG
(Pregnyl, Aboureihan, Tehran, Iran) was prescribed
to release the oocysts (10, 11). Then, on day
21 of the menstrual cycle (seven days after
the administration of HCG), endometrial biopsy
was performed using Novak curette to take
the samples from the anterior fundal section
of the uterus. We also took blood samples
for the measurement of serum progesterone.
Quantitative evaluation of uterine dome
density using scanning electron microscopy
was performed as previously described (12).
In summary, biopsy samples were washed
immediately in phosphate buffered (0.1mol/l,
PH 7.4) (PBS tablets, USA, MP Company) and
were then transferred to 2.5% Glutaraldehyde
(Germany, DSM company) for initial fixation.
Then, the samples were transferred to a solution
of 1% osmium tetroxide (Germany, Ridel de
Haen) as secondary fixation for at least 1 hr.
Thereafter, the samples were dehydrated in
a graded series of ethanol (5, 50, 70, 90,
99%) (Razi company, Iran), dried by machine
(Polaron CPD 7501 system (VG Microtech,
UK), and then mounted and covered by
gold in a Bio-Rad SC510 sputter coater (VG
Microtech).
Finally, the number of uterine domes in
experimental and control groups were counted,
at the same magnification in six random fields.
Thus, 30 random fields in each group were
assessed morphologically and statistically
trying to obtain samples from similar regions
of uterus (anterior-fundal wall of the uterus)
and in a specific time of cycle (on day 21).
Pinopods were evaluated as sphere-shaped
lumps without microvilli on the apical surface
of the endometrium and were semi-quantitatively
evaluated as lacking (0), isolated pinopods (+), small
clusters of pinopods (++), and feeder pinopods
(+++). To perform this electron microscopy by
ZEISS EVO Scanning Electron Microscope
(SEM) (Germany, Carl Zeiss Company, EVO
40), was used, and the number of pinopods
that were larger than 0.2 mm were counted per
mm.
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Enrollment
Assessed for eligibility (n = 42) Excluded (n = 12)
ØNot meeting inclusion criteria (prior 
IVF, hyper prolactinemia, thyroid
causes, endometriosis, ovulatory 
dysfunction, and uterine factors) (n = 8) 
ØDeclined to participate (n = 4)
Allocation
Randomized (n = 30)
Allocated to Control
(CC) (n = 10)
Allocated to intervention
(CC+EV) (n = 10)
Allocated to intervention
(CC+P) (n = 10)
Follow-up Lost to follow-up (n = 0)
Analysis Analysed (n = 10)
Lost to follow-up (n = 0) Lost to follow-up (n = 0)
Analysed (n = 10) Analysed (n = 10)
Figure 1. Flowchart of eligible patients.
2.3. Ethical consideration
This study was a prospective randomized
clinical trial, which was conducted at Imam
Hossein Hospital, a tertiary referral university
center. The research protocol was approved
by the Institutional Review Board and
ethics committee of the Shahid Beheshti
University of Medical Sciences, Tehran, Iran
(SBMU.RAM.REC.1386.16). Informed consent was
obtained from all patients before starting the
procedure.
2.4. Statistical analysis
In this pilot study, 30 patients were randomly
divided into three groups. We enrolled 10
patients in each group, which gave the study
a statistical power of 80% at alpha level 0.05.
Descriptive statistics are used to describe the
basic features of the data in a study. The data
analysis was done using SPSS for windows,
version 21.0 (IBM Corp., Armonk, NY). The Chi-
square test was used to compare frequencies.
Because of the small sample size, quantitative
data in three groups were analyzed using the
Kruskal-Wallis analysis. P < 0.05 was considered
statistically significant.
3. Results
There was no significant difference between
groups regarding the mean age (26.11 ± 3.37,
26.81 ± 2.85, 27.00 ± 4.30 respectively, p =
0.766). Also, there was no statistically significant
difference regarding pinopods concentrations,
serum estrogen levels on day 21 of the cycle and
the endometrial thickness, number and size of
ovarian follicles on day 14 of the cycle among the
three groups. The serum progesterone level on
day 21 of menstrual cycle among patients treated
with CC was higher than the other two groups
(34.98 ± 20.35 vs.8.87 ± 7.02 vs. 12.00 ± 9.52,
respectively, p = 0.007) (Table I).
Page 204 https://doi.org/10.18502/ijrm.v18i3.6718
International Journal of Reproductive BioMedicine Clomiphene and endometrial morphology
Table I. Comparison of cycle’s characteristics and pinopods ultrastructure and hormonal profile between the three groups of
patients
Variables Group I𝑎 Group II𝑏 Group III𝑐 P-value
Age (yr)* 26.11 ± 3.37 26.81 ± 2.85 27.00 ± 4.30 0.766
Pinopod concentration on day 21 (Pinopod ultrastructure)* 27.71 ± 21.85 39.42 ± 28.99 27.69 ± 19.05 0. 723
Serum estradiol levels on day 21* 243.24 ± 69.53 194.55 ± 152.58 262.12 ± 77.00 0.276
Endometrial thickness on day 14* 7.55 ± 1.74 7.87 ± 1.39 8.00 ± 1.85 0.903#
Serum progesterone levels on day 21* 34.98 ± 20.35 8.87 ± 7.02 12.00 ± 9.52 0.007#
Number of follicles ≥ 17 mm on day 14** 8 (88.9%) 8 (72.7%) 7 (87.5%) 0.577$
*Data presented as Mean ± SD, ** data presented as n(%); # ANOVA; $ Chi-square test was used
𝑎 Clomiphene citrate (CC) alone, 𝑏CC plus estradiol valerate (EV), 𝑐CC plus progesterone
4. Discussion
In this study, there was no significant difference
in the number of ovarian follicles greater than
17 mm in ultrasound on day 14 of the menstrual
cycle among patients treated with CC alone (group
I) compared to those treated with CC plus EV
(group II) and CC plus progesterone (group III). This
finding is supported by other studies that have
observed comparable efficacy when using CC or
CC plus estradiol regarding the number and size of
ovarian follicles in patients undergoing intrauterine
insemination (13, 14). However, Gerli and Unfer
and co-workers examined different forms of
estrogen as ethinyl estradiol and phytoestrogens
(13, 14), which are different from us. Also, they did
not investigate progesterone supplementation
effects. In our study, there was no difference
among patients in group I compared to those
in groups II and III regarding the endometrial
thickness on day 14 of the menstrual cycle. Similar
results have been reported by Check et al (15).
It may be due to higher estrogen secretion by
multiple follicular maturations on day 14 that
could compensate anti-estrogenic effects of CC.
Other researchers have found a decrease in
endometrial thickness in clomiphene alone when
they compared group I with group II (15-17). It
could be due to the suppression of endometrial
receptivity markers (HOXA10 and integrin alpha (v)
beta (3)) in rat by CC and the significant differences
between ovulation and pregnancy percentage
(18). Nevertheless, these authors investigated
more number of patients that may explain the
different results. Also Unfer et al, reported an
increase in endometrial thickness following the
addition of 1,500 mg daily phytoestrogens in 65
women with oligo menorrhea or amenorrhea who
were undergoing CC plus IUI (14). Yet, they used
different form and different dose of estrogen in
other type of population, which could explain the
different results. In recent study, there was no
significant difference in serum estradiol levels
on day 21 of menstrual cycles between the three
groups, but statistically significant differences
were observed in progesterone levels on day
21 in group I versus groups II and III. Contrary
to our study is one previous research about
CC treatment versus no treatment in infertile
women by Palomino et al. They demonstrated
that estradiol and progesterone levels in mid-
luteal phase was higher in CC treated groups
than the spontaneous endometrium but there
was no differences in the of plasma estradiol and
progesterone levels between out-of-phase and
in-phase endometrium (19). These results verify
an assumption that plasma levels of steroids are
independent from endometrial growth in (20). We
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did not find a significant difference considering the
pinopod concentrations on day 21 between the
three groups. Although, Pinopod concentration
was slightly higher in group II, it wasn’t significant.
Ganesh and co-workers found that when patients
with unexplained infertility were treated with
letrozole or CC, endometrial receptivity markers
such as αvβ3 integrin, L-selectin, leukemia
inhibitory factor (LIF), and pinopod concentrations
were meaningfully higher compared to controls
(21). However, they examined unexplained infertility
and didn’t use another hormonal supplementation
such as estradiol or progesterone that may
induce different effects. Cortínez et al. showed
complete expression of pinopode throughout the
implantation window of letrozole-treated group.
They found a small development in endometrial
maturation in letrozole group, which could be
described by the estrogen/progesterone ratio,
which favors progesterone in therapeutic cycles
(22). Pinopods is progesterone dependent. The
relationship between mid-luteal progesterone rise
and the first presence of pinopods during the
menstrual cycle was well-established (23).
This is also in line with the study by Omran
et al. that evaluated the effect of CC on uterine
artery blood flow using pulsed Doppler and
endometrial vascularization using 3D power
Doppler in unexplained infertility and found lower
endometrial flow in the stimulated cycles, but
there was no difference in serum estradiol and
progesterone concentrations between natural
and stimulated cycles (24) similar to us. However,
we did not use ultrasonography to access the
endometrium. Therefore, it can be investigated
in future researches among the three mentioned
treatment groups.
In one previous study, CC had shown a direct
influence reducing the pinopods formation in the
mid-luteal phase (16, 12). In a recent study, pinopods
concentration slightly increased with adding EV to
CC. It seems that induced pinopods concentration
by adding estradiol to CC or use of letrozole
may lead to better implantation and pregnancy
rates (1, 23, 25). In one study, researchers have
examined the distribution of the L-selectin ligand
(MECA-79) in human endometrial apical membrane
area during the implantation window. We found
higher expression of MECA-79 in pinopods in
mid-luteal phase compared to the utero dome-
free areas. These finding suggests a new role
for endometrial pinopods similar to endothelial
docking structures in tethering process, which
permits the leukocytes to move on the endothelial
cell wall (26). Since no other study has been
performed to compare pinopods concentrations,
further studies with larger sample size are needed
to better evaluate these variables and recognize
the effects of hormonal supplementation on
endometrial receptivity markers as pinopods.
In this study, there were higher levels of serum
progesterone on day 21 of the menstrual cycles in
the CC alone compared to the other two groups. It
is, therefore, essential to perform more extensive
studies with larger sample sizes.
5. Conclusion
There was no superiority of adding estradiol
or progesterone supplementation to clomiphene
citrate for enhancing pinopod concentration and
endometrial thickness or serum estradiol levels
in women who didn’t response to clomiphene
(Clomiphene failure). Yet, pinopod concentrations
is slightly increased with adding estradiol
which could be examined more again in future
researches. Thus, it can be concluded that the
anti-estrogenic effects of CC just appear on the
endometrium not on the plasma levels.
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